1,814
Views
1
CrossRef citations to date
0
Altmetric
Mental Health

Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans

, ORCID Icon, , , & ORCID Icon
Pages 422-429 | Received 03 Feb 2023, Accepted 03 Mar 2023, Published online: 22 Mar 2023